Illumina may also terminate, change, or otherwise modify any aspect of this Site, or impose limits on features or restrict access, in whole or in part, to this Site at any time and in its sole discretion without liability. Illumina may terminate any authorizations, rights, and licenses provided herein, and upon such termination, you shall immediately destroy all materials obtained from this Site.
Illumina authorizes you to view and download the materials at this Site, provided that (i) you retain all copyright and other proprietary notices contained in the original materials on any copies of the materials, (ii) your use of such materials is for your personal, non-commercial use only, and will not be copied or posted on any network computer or broadcast in any media, (iii) you may not modify the materials in any way or reproduce, publicly display, perform, distribute, transmit, or create derivative works from any of the materials on this Site, and (iv) you may not transfer the materials to any other person unless you give them notice of, and they agree to accept, these terms and conditions. The above authorization does not include the design or layout of this Site, elements of which are legally protected and may not be copied or imitated in whole or in part. No logo, graphic, sound, or image from this Site may be copied or retransmitted unless expressly authorized by Illumina. No other use of the materials is authorized. The materials at this Site are proprietary and any unauthorized use of any materials at this Site may violate copyright, trademark, and other laws.
Access to password-protected and/or secure areas of this Site is limited to authorized users only and requires creation of an account. You must provide complete and accurate information on your account and update such information as necessary. You are responsible for maintaining the confidentiality of your account and password information, and you agree not to share or distribute your password information. You agree to notify Illumina immediately of any unauthorized use of your account or any other breach of security. You further agree to accept responsibility for all activities that occur under your account or password.
Any links to third-party websites that may appear on this Site are provided only as a convenience to you and in no way imply any affiliation, sponsorship, endorsement, or acceptance of any information or views provided on those linked websites. Illumina does not monitor the linked websites for accuracy or content, and does not warrant the information contained thereon. The information provided on the linked websites and any warranty with regard thereto is solely the responsibility of the providers of that information. If you decide to access third-party websites through links from this Site, you do so at your own risk.
Links to this site
All links to the Site must be approved in writing by Illumina; however, Illumina consents to links limited to those in which:
(i) the link is a text-only link containing only the name "Illumina";
(ii) the link redirects the user only to www.illumina.com and not to deeper pages;
(iii) the link, when activated, displays that page full-screen in a fully operable and navigable browser window and not within a "frame" on the linked website;
(iv) the appearance, position, and other aspects of the link do not present false information about Illumina products, services, or technology, nor be such as to damage or dilute the goodwill associated with the name and trademarks of Illumina, nor create the false appearance that another entity or its activities or products are associated with or sponsored or endorsed by Illumina; and
(v) No Illumina logo or trademark is used or appears.
YOU AGREE THAT YOUR USE OF THIS SITE SHALL BE AT YOUR SOLE RISK. THE OPERATION OF THIS SITE AND THE INFORMATION AVAILABLE THEREON ARE PROVIDED "AS IS." TO THE FULLEST EXTENT PERMITTED BY LAW, ILLUMINA, ITS OFFICERS, DIRECTORS, EMPLOYEES, AND AGENTS DISCLAIM ALL WARRANTIES, EXPRESS OR IMPLIED, IN CONNECTION WITH THIS SITE AND YOUR USE THEREOF. ILLUMINA MAKES NO WARRANTIES OR REPRESENTATIONS ABOUT THE ACCURACY OR COMPLETENESS OF THIS SITE'S CONTENT OR THE CONTENT OF ANY SITES LINKED TO THIS SITE AND ASSUMES NO LIABILITY OR RESPONSIBILITY FOR ANY (I) ERRORS, MISTAKES, OR INACCURACIES OF CONTENT, (II) PERSONAL INJURY OR PROPERTY DAMAGE, OF ANY NATURE WHATSOEVER, RESULTING FROM YOUR ACCESS TO AND USE OF THIS SITE, (III) UNAUTHORIZED ACCESS TO OR USE OF OUR SECURE SERVERS AND/OR ANY AND ALL PERSONAL INFORMATION STORED THEREIN, (IV) INTERRUPTION OR CESSATION OF TRANSMISSION TO OR FROM THIS SITE, (V) BUGS, VIRUSES, WORMS, TROJAN HORSES, SPYWARE, OR ANY OTHER MALWARE, OR THE LIKE THAT MAY BE TRANSMITTED TO OR THROUGH THIS SITE BY ANY THIRD PARTY, (VI) ERRORS OR OMISSIONS IN ANY INFORMATION, AND/OR (VII) LOSS OR DAMAGE OF ANY KIND INCURRED AS A RESULT OF THE USE OF ANY INFORMATION POSTED, EMAILED, TRANSMITTED, OR OTHERWISE MADE AVAILABLE VIA THIS SITE.
IN NO EVENT SHALL ILLUMINA ITS OFFICERS, DIRECTORS, EMPLOYEES, OR AGENTS, BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES WHATSOEVER ARISING UNDER OR AS A RESULT OF THESE TERMS AND CONDITIONS, THE USE OR INABILITY TO USE THIS SITE OR THE CONTENTS OF THIS SITE, WHETHER BASED ON WARRANTY, CONTRACT, TORT, OR ANY OTHER LEGAL THEORY, AND WHETHER OR NOT ILLUMINA IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. THE FOREGOING LIMITATION OF LIABILITY SHALL APPLY TO THE FULLEST EXTENT PERMITTED BY LAW IN THE APPLICABLE JURISDICTION.
The Illumina logo and names of Illumina products or services displayed on this Site are protected by U.S. and international trademark and copyright laws. All trademark name representations and listed owners are believed to be accurate, but not guaranteed to be so.
24sure, Ampligase, Assign, BaseSpace, BlueFish, BlueFuse, BlueGnome, Clarity LIMS, CSPro, CytoSeq, DesignStudio, Durascript, Genetic Energy, GenomeStudio, Globin-Zero, GoldenGate, HiSeq, iSeq, iHope, Illumina, Illumina Propel Certified, IllumiNotes, Infinium, iScan, iSelect, MiniSeq, MiSeq, MiSeqDx, NextBio, Nextera, NextSeq, NovaSeq, Powered by Illumina, Ribo-Zero, SeqMonitor, SureCell, TruGenome, TruSeq, TruSight, Understand Your Genome, UYG, Verifi, Verinata, Verinata Health, VeriSeq, the pumpkin orange color, and the Genetic Energy streaming bases design are trademarks or registered trademarks of Illumina, Inc.
Other third party trademarks referenced on this Site, including but not limited to those listed below, are the property
of their respective owners.
• AmpliSeq is a trademark of Thermo Fisher Scientific
• ddSEQ is a trademark of Bio-Rad Laboratories, Inc.
• xGen is a trademark of Integrated DNA Technologies, Inc.
• FusionPlex is a trademark of ArcherDx, Inc.
No license to use any of Illumina's trademarks is given or implied. Users are not permitted to use these trademarks without the prior written consent of Illumina. The use of these trademarks or any other materials, except as permitted herein, is expressly prohibited and may be in violation of federal or other applicable laws.
DIGITAL MILLENNIUM COPYRIGHT ACT (“DMCA”) NOTICE
The Digital Millennium Copyright Act of 1998, found at 17 U.S.C. § 512 (“DMCA”), provides recourse for copyright owners who believe their rights under United States copyright law have been infringed. Pursuant to the DMCA, anyone who believes their material has been used in a way that constitutes copyright infringement may submit a notification of copyright infringement to a designated agent for the website.
We respect the intellectual property rights of others and are committed to complying with United States copyright law, as well as international trade law and practices. Therefore, upon receipt of a proper notification of copyright infringement under the DMCA, we will remove and/or block access to the allegedly infringing material.
To be valid, notifications must be sent to our DMCA designated agent, identified below:
Susan E. Farley, Esq.
Heslin Rothenberg Farley & Mesiti P.C.
5 Columbia Circle
Albany, New York 12203
To be effective under the DMCA, a copyright notice must be a written communication that includes the following information:
Except as otherwise provided, Illumina owns all content contained in this Site, including without limitation the information, materials, text, graphics, Site design, and the selection, assembly and arrangement thereof ("Content"). The Content is protected by copyright laws of the U.S. and other countries.
Content published on this Site may contain other proprietary notices or describe products, services, processes, or technologies owned by Illumina or third parties. Please note that by publishing this Content, Illumina is not granting any license under any copyright, trademark, patent, or other intellectual property right of Illumina or any third party.
Except for the rights granted in these terms and conditions, no Content on this Site may be copied, distributed, displayed, modified, reproduced, performed, published, posted, or reverse engineered in whole or in part in any way, stored or transmitted by any means, including but not limited to electronic, mechanical, scanning, photocopying, or recording, without the prior written permission of Illumina. You also may not, without our permission, "mirror" any Content on this Site, and such use of any Content on any other website or networked computer environment is expressly prohibited. Modification of the Content or use of the Content on this Site for any other purpose is a violation of Illumina's copyright and other proprietary rights.
Illumina is constantly conducting research and development, leading to new, modified, and/or improved technology and products. It is Illumina's policy to seek patent protection in the United States and abroad for such technology and products.
Any software that is made available to download from this Site is the copyrighted work of Illumina and/or its suppliers, and is governed by the terms of the end user license agreement, if any, that accompanies or is included with the software. You may not download or install any software from this Site that is accompanied by or includes a license agreement unless you have read and accepted the terms of the license agreement. Any unauthorized use, reproduction, or redistribution of the software is prohibited.
This Site is controlled and operated by Illumina from its offices within the United States. Illumina makes no representations that this Site is appropriate or available for use in other locations. Those who choose to access this Site from locations outside the United States do so on their own initiative and are responsible for compliance with applicable local laws. You may not use or export the materials in violation of United States export laws and regulations. Any and all actions, claims, disputes, or controversies relating to these terms and conditions, the use of this Site, or any materials therein shall be governed by the law of the State of California, USA, without regard to its conflict-of-laws principles. By using this site, you expressly consent to the exclusive forum, jurisdiction, and venue of the state and federal courts of San Diego County, California, USA in such actions, claims, disputes, or controversies.
Cal. Civil Code section 1714.43
Illumina respects the human rights of workers within its direct supply chain. Illumina’s efforts in this area include: the use of contract provisions with Illumina direct suppliers requiring their compliance with applicable labor laws and barring those suppliers from the use of child, slave or forced labor; inquire as to use of child, slave or forced labor and compliance with labor laws during pre-arranged Illumina conducted audits; requesting that new direct suppliers certify their compliance with applicable labor laws including that they do not use child, slave or forced labor; training to employees working with direct suppliers to bring attention to this law and the issue of human trafficking and slavery; training to employees working with direct suppliers about the contract.
President & CEO
Code of Conduct
Illumina is committed to conducting its business in compliance with all applicable laws and regulations, and with the highest ethical standards. Based on this commitment, Illumina has adopted a Code of Conduct that applies to all of its employees, consultants, temporary workers, officers, and members of the Board of Directors, regardless of location, seniority level, business unit, function, or region. Illumina’s Code of Conduct requires full compliance with all applicable laws and regulations, including the UK Modern Slavery Act 2015. The Code of Conduct shares Illumina’s principles and values on treating people honestly, fairly, and with respect, and it defines Illumina’s policy for promoting ethical business conduct.
Contractual Controls and Audits
Illumina requires by contract, and conducts audits to ensure, that its suppliers comply with applicable laws and regulations.
Illumina provides training on its Code of Conduct for new and existing employees as well as training on other company policies. Training is conducted through Illumina’s Learning Management System and training records are documented for all employees.
As Illumina expands its business activities and works with suppliers domestically and globally, Illumina remains committed to human rights and safety and ensuring that no Modern Slavery is involved in our operations or supply chain.
“Conflict minerals” – tantalum, tin, gold, or tungsten – that originate from the Democratic Republic of Congo (DRC) or adjoining countries are sometimes mined and sold by armed groups to finance civil violence. These minerals can make their way into the supply chains of products used by consumers and businesses around the world.
In 2010, the U.S. Congress enacted the Dodd-Frank Wall Street Reform and Consumer Protection Act, which requires U.S. Securities and Exchange Act reporting companies, such as Illumina, to disclose their use of such conflict minerals beginning in 2014.
Conflict-Free Minerals Policy
Illumina supports the goal of avoiding the use of conflict minerals that directly or indirectly benefit armed groups in the DRC or adjoining countries.
Accordingly, Illumina expects its suppliers to commit to the EICC Code of Conduct, which was established by the Electronic Industry Citizenship Coalition (EICC) to ensure worker safety and fairness, environmental responsibility, and business efficiency. The EICC Code of Conduct includes a provision related to the responsible sourcing of minerals and requires suppliers to have a policy to reasonably assure that the tantalum, tin, tungsten, and gold in the products they manufacture does not directly or indirectly finance or benefit armed groups that are perpetrators of serious human rights abuses in the DRC or an adjoining country. Illumina expects its suppliers to establish their own due diligence program to ensure supply chains that are free of conflict minerals and to make their due diligence measures available to Illumina upon request.
Illumina will routinely evaluate its suppliers to ensure that they are adhering to Illumina’s expectations and values.
Illumina, Inc. (“Illumina”) has established one or more policies and processes (the “Compliance Program”) to comply
with California’s healthcare professional aggregate spend law, Cal. Health & Safety Code §§ 119400-119402
(the “Law”). This Statement on Compliance with California Law is applicable to any Illumina personnel
who interact with California healthcare professionals as defined in the Law.
ANNUAL DECLARATION OF COMPLIANCE WITH CALIFORNIA LAW
Illumina is committed to conducting its business ethically and in compliance with all applicable laws. To the best of its knowledge and based on a good faith understanding of the statutory requirements, Illumina has established the Compliance Program to meet the requirements set forth in the Law. Illumina has tailored the Compliance Program to meet the specific needs of Illumina and periodically assesses the effectiveness of the Compliance Program. Thus, subject to the limitations described above, Illumina declares that Illumina is, in all material respects, in compliance with the Compliance Program and with the respective established annual spending limits for reporting period of June 1 through May 31.
As recognized by the United States Office of Inspector General’s (“OIG”) Compliance Guidance, even an effective compliance program cannot eliminate the possibility that one or more individual employees could engage in conduct that would be considered improper. Accordingly, this declaration is not intended, and should not be construed to imply, that there have not been violations of the Compliance Program nor that Illumina has not identified any individual instances in which there may have been violations of one or more provisions of the Compliance Program.
For a written copy of the compliance program description
or this declaration, call 800.809.4566 (please ask to speak with the Legal Compliance department).